Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03445585 · ClinicalTrials.gov registry record
Biobank for Cholestatic Liver Diseases.
A clinical trial of Liver Cancer and Cholangiocarcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 9,150
- Enrollment target
- 1
- Study location
NCT03445585: Recruiting study of Liver Cancer and Cholangiocarcinoma, sponsored by Mayo Clinic.
NCT03445585 is a study of Liver Cancer and Cholangiocarcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 9,150 participants, above the 331-participant average among 78 other Liver Cancer trials with a reported enrollment target (2664% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03445585, a study of Liver Cancer and Cholangiocarcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 9,150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver diseases primary biliary cirrhosis/cholangitis (PBC) and primary sclerosing cholangitis (PSC).
Primary Outcome
Number of participants in the study.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,150 participants |
| Start Date | 2017-01 |
| Est. Completion | 2050-01 |
What NCT03445585 shows while recruiting
NCT03445585 is an observational study that tracks outcomes without assigning an intervention. Its 9,150 participants enrollment target places it among the larger protocols in the corpus, above the 331-participant average among 78 other Liver Cancer trials with a reported enrollment target (2664% higher).
The record links to 4 conditions, with Liver Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03445585 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03445585 about?
NCT03445585 is a clinical study titled "Biobank for Cholestatic Liver Diseases.". This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver diseases primary biliary cirrhosis/cholangitis (PBC) and primary sclerosing cholangitis (PSC).
What is the current status of trial NCT03445585?
This trial is currently recruiting. The enrollment target is 9,150 participants. The study started on 2017-01. Estimated completion is 2050-01.
What conditions does trial NCT03445585 study?
This clinical trial studies the following conditions: Liver Cancer, Cholangiocarcinoma, Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis.
Who is sponsoring clinical trial NCT03445585?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03445585 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03445585's enrollment target sits among peer trials
9,150 1st of 78 higher than 78 of 78 other Liver Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility Study of CBCT for IGRT in Cancer Patients
RECRUITING · NA
-
Collection of Blood From Patients With Cancer
RECRUITING
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
RECRUITING · NA
-
Multi-analyte Blood Test Clinical Trial
RECRUITING
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06946355 · 9,119 participants · NA
Food-based Support for Hospitalized Children and Their Families
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- NCT06284408 · 9,460 participants · NA
Centralized Screening Unit (CSU) at Montefiore-Einstein
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia